溶解在肺部疾病中的治疗潜力
Daniel Centanni1, Paul A J Henricks1, Ferdi Engels1
1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, the Netherlands.
European journal of pharmacology
|September 24, 2023
概括
来自omega-3脂肪酸的溶液,促进炎症的解决. 这些分子通过调节炎症过程,为各种肺部疾病提供治疗潜力.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 无法控制的炎症会导致组织损伤,并导致许多病理,特别是肺部疾病.
- 刺激炎症解消对于预防慢性炎症疾病进展至关重要.
- 从omega-3脂肪酸中生成的溶解素是具有亲溶解和抗炎性质的关键信号分子.
研究的目的:
- 审查解决方案的生成和机制.
- 研究溶解素在肺部疾病中的作用和治疗潜力.
- 突出在炎症治疗中转向基于解决方案的治疗方法的转变.
主要方法:
- 关于溶解素和肺部疾病的科学文献的审查.
- 解析溶解素在调节炎症通路中的机械作用.
- 探索改变分辨率与肺部疾病病理生理学之间的联系.
主要成果:
- 溶解素与特定的受体结合,调节中性粒细胞迁移,巨细胞化和促炎媒介.
- 改变的炎症分辨率与喘,COPD,囊性纤维化,ARDS,癌症和COVID-19的发展和恶化有关.
- 溶解的发现刺激了基于溶解的新型治疗方法的发展.
结论:
- 溶解素代表了由炎症为特征的肺部疾病的有前途的治疗策略.
- 针对炎症解决方案为治疗炎症疾病提供了一个新的范式.
- 对溶解素的进一步研究可能会导致一系列肺部疾病的创新治疗方法.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
474
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
474
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
203
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
203
Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
Respiratory Volumes
1.5K
Respiratory volumes are crucial metrics, meticulously measured to quantify the air exchanged in and out of the lungs during various phases of the breathing cycle. These precise measurements are vital for assessing lung function, diagnosing respiratory conditions, and monitoring overall respiratory health. Each parameter provides specific insights into the mechanics of breathing and the functional capacity of the lungs.
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
1.5K
Asthma: Pathogenesis and Management
433
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
Drugs Used in Upper Respiratory Disorders: Overview
279
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
279


